S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

RPHM Reneo Pharmaceuticals Inc

18.20

0.00 (0.00%)

After Hours

Last Updated: 19:00:00

Delayed by 15 minutes

Form S-1 - General form for registration of securities under the Securities Act of 1933

Article too big to display. Click here to view on the SEC website

Reneo Pharmaceuticals (NASDAQ:RPHM)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Reneo Pharmaceuticals Charts.

Reneo Pharmaceuticals (NASDAQ:RPHM)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Reneo Pharmaceuticals Charts.

Reneo Pharmaceuticals Inc News

Form S-8 - Securities to be offered to employees in employee benefit plans
Monday 10 March 2025 (1 day ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 10 March 2025 (1 day ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 10 March 2025 (1 day ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Monday 10 March 2025 (1 day ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 10 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 10 December 2024 (3 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Monday 9 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (4 months ago) • Edgar (US Regulatory)

More Reneo Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions